EU – Page 3 – HealthQuill

GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.

GSK Plc gets EU approval for HIV prevention drug Apretude

GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.

by HealthQuill
September 20, 2023
0 Comments

The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss or alopecia aerate.

Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.

by HealthQuill
September 19, 2023
0 Comments

The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of the bone marrow.

Drugs Health Pharma

EMA recommends stopping sale of GSK’s blood cancer drug in EU

The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of.

by HealthQuill
September 15, 2023
0 Comments

Methamphetamine trafficking is expanding rapidly from the EU to Eastern Africa, changing illicit drug markets traditionally focused on opiates from Afghanistan, according to a UN report.

Drugs Health Pharma

Illicit meth from Afghanistan a growing global threat: UN body

HQ Team September 12, 20232: Methamphetamine trafficking is expanding rapidly from the EU to Eastern Africa, changing illicit drug markets traditionally focused on.

by HealthQuill
September 12, 2023
0 Comments

A panel of the European Union’s health regulator, the European Medicines Agency, has warned against the use of topiramate medicines during pregnancy as it may result in serious birth defects.

Drugs Health Pharma

EMA cautions against topiramate medicine use during pregnancy

HQ Team September 2, 2023: A panel of the European Union’s health regulator, the European Medicines Agency, has warned against the use of.

by HealthQuill
September 2, 2023
0 Comments

Drugs Health Pharma

France’s Ipsen clears FDA hurdle for bone disorder drug Sohonos

HQ Team August 17, 2023: Ipsen, a French drugmaker, has received FDA approval for its Sohonos capsules to treat a rare bone disorder.

by HealthQuill
August 17, 2023
0 Comments

Italy’s lower house unanimously green-lighted a ‘right to be forgotten’ bill to protect cancer survivors from insurance agencies and banks, which ask for their prior condition.

Drugs Health Pharma

Italian lower house clears right to be forgotten bill for cancer patients

HQ Team August 7, 2023: Italy’s lower house unanimously green-lighted a ‘right to be forgotten’ bill to protect cancer survivors from insurance agencies.

by HealthQuill
August 7, 2023
0 Comments

A hunting community, as far as Northeastern Greenland has some of the world’s highest concentrations of harmful polyfluoroalkyl substances (PFAS), a Danish study found.

Climate Drugs Pharma

Greenland’s hunting community reports high PFAS levels

HQ Team July 13, 2023: A hunting community, as far as Northeastern Greenland has some of the world’s highest concentrations of harmful polyfluoroalkyl.

by HealthQuill
July 13, 2023
0 Comments

British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.

Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.